August 06, 2026
A Washington, D.C., federal judge on Thursday largely sided with the U.S. Securities and Exchange Commission in its civil enforcement case against the former CEO of RTI Surgical Holdings, finding he misled investors by failing to disclose that the surgical implant company regularly shipped orders early to artificially inflate its quarterly revenues.
August 03, 2022
The U.S. Securities and Exchange Commission announced Wednesday that a surgical implant company agreed to pay $2 million to end a suit alleging company executives shipped products early to mask failed sales targets, but the company's former CEO said that evidence at trial will show he committed no wrongdoing.